The consequences of President Trump's actions on drug pricing continue to play out, with Bristol Myers Squibb insisting it will charge the same in the UK for new schizophrenia drug Cobenfy as in the ...

Bristol Myers Squibb has expanded its direct-to-consumer (DTC) sales of medicines in the US with the addition of its psoriasis therapy Sotyktu. All of the DTC channels offer discounts for people ...

Bristol Myers Squibb and Johnson & Johnson have begun an educational campaign about the factor XIa pathway, laying the groundwork for a launch that could follow phase 3 readouts expected this year.

Bayer has linked asundexian to a 26% reduction in stroke in a phase 3 study, setting the bar for Bristol Myers Squibb and Johnson & Johnson’s rival factor XIa inhibitor in a blockbuster indication.

The Blitzboks finished fourth after a narrow Cup third-playoff loss to New Zealand in the Singapore Sevens on Sunday. New Zealand beat South Africa 14-12 after leading 7-5 at half-time. New Zealand ...

New Zealand earlier produced a dominant win over arch-rivals Australia in the women's final. Fiji beat France for third place in the opening two legs of the 2025–26 series in Dubai and Cape Town, but ...

Australia Men's Sevens captain Henry Hutchison believes an elusive home title will be the perfect way to celebrate his new cap record as the SVNS World Series returns to Perth. Hutchison surpassed the ...

The Black Ferns Sevens have continued their recent dominance over Australia, toppling their nearest rivals 29-7 on home soil in the final of the Perth Sevens. Australia, who had won their last 10 ...

Faith Nathan scores a scorching try against Great Britain in Australia Sevens Women's opening match of HSBC SVNS Perth Australia have completed a perfect day to start Perth, sweeping through the pool ...

Bristol Myers Squibb (NYSE: BMY) today reported fourth quarter and full-year 2025 financial results. Visit the company’s Investor Relations website at http ...

CEO Christopher Boerner opened by highlighting, “2025 was a year of focused execution across the business. We believe our results further demonstrate the ongoing strength in our growth portfolio as we ...